期刊文献+

缬沙坦对cGVHD狼疮样肾炎小鼠肾组织中MMP-9/TIMP-1表达的影响 被引量:1

Effect of Valsartan on the expressions of MMP-9/TIMP-1 in kidney tissue of murine chronic graft-versus-host disease lupus nephritis
原文传递
导出
摘要 目的:观察缬沙坦对慢性移植物抗宿主病(cGVHD)狼疮样肾炎小鼠肾组织中基质金属蛋白酶-9(MMP-9)、组织金属蛋白酶抑制剂-1(TIMP-1)表达的干预作用,探讨缬沙坦对肾脏的保护机制。方法:18只B6D2F1代杂交鼠,随机分为狼疮肾炎模型组(12只)和对照组(6只)。随机将狼疮肾炎模型组分为模型组(6只)和缬沙坦组(6只)。双缩脲法测定24h尿蛋白量;免疫组织化学染色法及反转录-聚合酶链反应(RT-PCR)法观察肾组织中MMP-9、TIMP-1表达;明胶酶谱法检测MMP-9活性。结果:与对照组相比,狼疮肾炎模型组小鼠24h尿蛋白量、MMP-9、TIMP-1表达及比值均增加,MMP-9活性增强,且与系膜细胞增殖呈正相关;与模型组相比,缬沙坦组尿蛋白量、MMP-9、TIMP-1表达及比值均降低,MMP-9活性下降。结论:缬沙坦降低MMP-9、TIMP-1表达及MMP-9活性,改善MMP-9/TIMP-1失衡,从而发挥肾脏保护作用。 OBJECTIVE The aim of the present study was to determine whether Valsartan affects the expressions of matrix metalloproteinase-9(MMP-9)and tissue inhibitor of metalloproteinase-1 (TIMP-1)in kidney tissue of murine chronic graft-versus-host disease lupus nephritis and evaluate the renoprotective effect of Valsartan. METHODS Eighteen female age-matched (C57BL/6J × DBA/2) F1 mice were randomly divided into two groups., control mice and cGVHD mice. The cGVHD mice were randomly divided into two groups: untreated mice, treated mice with Valsartan. The levels of urinary protein were measured in the 24 h urine collections using the blure T. protein assay as a marker of renal damage. Immunohistochemistry and RT-PCR were used to observe the expressions of MMP-9, TIMP-1 in kidney tissue. Gelatin zymography was employed to perform MMP-9 activity examination. RESULTS Urinary protein excretion was increased significantly in cGVHD mice compared with the control mice. The cGVHD mice were found to have markedly intense staining of MMP-9, TIMP-1 mainly in tubular epithelial cells and walls of vessels. The level of glomerular MMP-9 staining correlated significantly with the level of total glomerular cell proliferation. The cGVHD mice displayed instinctively upregulated the ratio of MMP-9/TIMP-1 and increased MMP-9 activity. The treated mice had less proteinuria than untreated mice. The rate of MMP-9/TIMP-1 and gelatinolytic activity of MMP-9 in treated-mice were significantly reduced. CONCLUSION The imbalance of MMP-9 and TIMP-1 will lead to the regression of renal in lupus nephritis. Valsartan plays an important role in the regulation of the balance of MMP-9 and TIMP-1, which will prevent progressive kidney failure of lupus nephritis.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第2期105-110,共6页 Chinese Journal of Hospital Pharmacy
关键词 慢性移植物抗宿主病 狼疮肾炎 缬沙坦 基质金属蛋白酶-9 组织金属蛋白酶抑制剂-1 Chronic graft-versus-host disease Lupus nephritis Valsartan Matrix metalloproteinase-9 Tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献17

  • 1Thomas M, Blennerhassett J, Walker R. Relapse with trans formation of lupus nephritis in a transplant kidney[J]. Lupus, 2005, 14: 554-556.
  • 2Bruijn JA, Van Eleven EH, Higendoorm PCW, et al. Murine chronic graft-versus-host disease a model for lupus nephritis [J]. Am J Path, 1988, 130:639-640.
  • 3Maki Urushihara, Shoji Kagami, Takashi Kuhara, et al. Glomerular distribution and gelatinolytic activity of matrix metal loproteinases in human glomerulonephritis[J]. Nephrol Dial Transplant, 2002, 17:1189-1196.
  • 4Arbuckle MR, Mcclain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus[J]. N Engl J Med, 2003,349 : 1526-1533.
  • 5Chromek M, Tullus K, Hertting O, et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring [J]. Pediatric Research, 2003, 53(4):698-705.
  • 6Makowski GS, Ramsby ML. Concentrations of circulating ma trix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus[J]. Mol Pathol, 2003, 56(4): 244-247.
  • 7Johann Sellner, Stephen L, Leib. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP 1 ratio and increased collagen type IV degradation[J]. Neurobiology of Disease, 2006, 21: 647-656.
  • 8McQuibban GA, Gong JH, Wong JP, et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo[J]. Blood, 2002, 100:1160-1167.
  • 9Corry DB, Rishi K, Kanellis J, et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2 deficiency[J]. Nat lmmunol, 2002, 3: 347-353.
  • 10Lim S, Roche N, Oliver B. G, et al. Balance of matrix metalloprotease 9 and tissue inhibitor of metalloprotease-1 from alveolar maerophages in cigarette smokers regulation by inter leukin-10[J]. Am J Respir Crit Care Med, 2000, 162: 1355-1360.

同被引文献36

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部